Watch an overview of the BIR therapy webinars by series organisers including Dr Gopinath Gnanasegaran (BIR), Dr Sridhar Redla (BIR), Dr Diana Paez (IAEA) and Dr Partha Choudhury (WARMTH) in this introductory video and see the suite of webinars below.
Read an overview and introduction to the BIR Radionuclide Therapy Webinar Series by Dr Gopi Gnanasegaran
VIEW THE THERAPY WEBINAR PROGRAMME HERE
Dr Francis Sundram discusses the use of Radium-223 as a targeted therapy for the treatment of metastatic prostate cancer.
Dr Francesco Giammarile gives an overview of theranostics, as well as looking at possible radionuclide treatments.
Dr Jim Ballinger examines the use of radiopharmaceuticals for radionuclide therapy by reviewing the basic concepts of beta and alpha radionuclides.
Professor John Buscombe explains the use of the radiopharmaceutical mIBG.
Professor Hojjat Ahmadzadehfar presents the basics followed by the results of using Lu-PSMA therapy in metastatic prostate cancer.
Professor Mariza Vorster explores why 225Ac-PSMA therapy is needed, how it works as a treatment and what the potential side effects are.
Dr Willm Uwe Kampen provides and analysis of the science and practice behind radiosynoviorthesis.
Dr Macarena Rodriguez-Fraile talks about selective internal radiation therapy with Yttrium 90.
Professor José Jaureguizar reviews the principals and basic concepts of selective internal radiation therapy.
Professor Manuel Weber conveys the science and practice behind selective internal radiation therapy - TheraSphere.
Dr Nicolas Lepareur discusses the advantageous properties of Rhenium-188 and why it presents an exciting radionuclide for therapeutic purposes.
Dr B A Krishna looks at the origin, evolution and future of radionuclide therapy.
Mr Richard Meades importantly highlights the radiation protection aspects of Radionuclide therapies.
Professor Sandip Basu summarises the science and practice behind the Radionuclide Bone Palliation Therapy.
Professor Prasanta Pradhan covers the science and practice behind radio-iodine therapy in benign thyroid disease.
Mr Josh Mailman guides you through 'a patient's journey' from diagnosis to treatment and thereafter.
Dr Gopinath Gnanasegaran talks about peptide receptor radionuclide therapy in neuroendocrine tumours.
Professor Julia Tietze from OncoBeta discusses the use of Rhenium-SCT (Skin Cancer Therapy) as an alternative approach to treat Non- Melanoma skin cancer. Dr Paolo Castellucci will then explore epidermal radioisotope therapy with rhenium-188.
